The activity of IDH1 enzyme in protecting CSC from oxidative damage has also been observed in glioma-initiating cells (GIC), where IDH1 inactivation, via silencing or pharmacological inhibition, diminishes NADPH production, reduces GSH levels, and increases ROS, thereby reducing GIC frequency [48]. Here, IDH1 is linked to glioma.